BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 33841576)

  • 1. Erratum: Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP-2 and MMP-9 expression via the p38MAPK signaling pathway.
    Lu S; Zhang Z; Chen M; Li C; Liu L; Li Y
    Oncol Lett; 2021 May; 21(5):415. PubMed ID: 33841576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP-2 and MMP-9 expression via the p38MAPK signaling pathway.
    Lu S; Zhang Z; Chen M; Li C; Liu L; Li Y
    Oncol Lett; 2017 Dec; 14(6):7577-7582. PubMed ID: 29344204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.
    Chen L; Pan Y; Gu L; Nie Z; He B; Song G; Li R; Xu Y; Gao T; Wang S
    Exp Biol Med (Maywood); 2013 Aug; 238(8):903-12. PubMed ID: 23828593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma.
    Hu Q; Li L; Zou X; Xu L; Yi P
    Front Pharmacol; 2018; 9():1150. PubMed ID: 30405404
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
    Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
    Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DJ-1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway.
    Zhu ZM; Li ZR; Huang Y; Yu HH; Huang XS; Yan YF; Shao JH; Chen HP
    Oncol Rep; 2014 Mar; 31(3):1489-97. PubMed ID: 24398929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells.
    Oh SJ; Jung SP; Han J; Kim S; Kim JS; Nam SJ; Lee JE; Kim JH
    Oncol Rep; 2013 Apr; 29(4):1343-8. PubMed ID: 23353996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21WAF1 Is Required for Interleukin-16-Induced Migration and Invasion of Vascular Smooth Muscle Cells via the p38MAPK/Sp-1/MMP-9 Pathway.
    Park SL; Hwang B; Lee SY; Kim WT; Choi YH; Chang YC; Kim WJ; Moon SK
    PLoS One; 2015; 10(11):e0142153. PubMed ID: 26544695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway.
    Zhang ZD; Li Y; Fan Q; Zhao B; Tan B; Zhao XF
    Neoplasma; 2014; 61(6):627-37. PubMed ID: 25150310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tspan9 inhibits the proliferation, migration and invasion of human gastric cancer SGC7901 cells via the ERK1/2 pathway.
    Li PY; Lv J; Qi WW; Zhao SF; Sun LB; Liu N; Sheng J; Qiu WS
    Oncol Rep; 2016 Jul; 36(1):448-54. PubMed ID: 27177197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
    Gao P; Wang S; Jing F; Zhan J; Wang Y
    Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
    Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
    Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin inhibits the invasion of IL-6-stimulated colon cancer cells via selective JNK/AP-1/MMP-2 modulation in vitro.
    Lin CM; Chen YH; Ma HP; Wang BW; Chiu JH; Chua SK; Ong JR; Shyu KG
    J Agric Food Chem; 2012 Dec; 60(51):12451-7. PubMed ID: 23210512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silibinin inhibits migration and invasion of the rhabdoid tumor G401 cell line via inactivation of the PI3K/Akt signaling pathway.
    Li Y; Zhang C; Cai D; Chen C; Mu D
    Oncol Lett; 2017 Dec; 14(6):8035-8041. PubMed ID: 29344246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Beclin-1 knockdown decreases proliferation, invasion and migration of Ewing sarcoma SK-ES-1 cells via inhibition of MMP-9.
    Ye C; Yu X; Liu X; Zhan P; Nie T; Guo R; Liu H; Dai M; Zhang B
    Oncol Lett; 2021 Feb; 21(2):111. PubMed ID: 33376544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. shRNA-interfering LSD1 inhibits proliferation and invasion of gastric cancer cells
    Pan HM; Lang WY; Yao LJ; Wang Y; Li XL
    World J Gastrointest Oncol; 2019 Aug; 11(8):622-633. PubMed ID: 31435463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EPO gene expression promotes proliferation, migration and invasion via the p38MAPK/AP-1/MMP-9 pathway by p21WAF1 expression in vascular smooth muscle cells.
    Park SL; Won SY; Song JH; Kambe T; Nagao M; Kim WJ; Moon SK
    Cell Signal; 2015 Mar; 27(3):470-8. PubMed ID: 25496832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells.
    Lee SO; Jeong YJ; Im HG; Kim CH; Chang YC; Lee IS
    Biochem Biophys Res Commun; 2007 Mar; 354(1):165-71. PubMed ID: 17214970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sinulariolide Inhibits Gastric Cancer Cell Migration and Invasion through Downregulation of the EMT Process and Suppression of FAK/PI3K/AKT/mTOR and MAPKs Signaling Pathways.
    Wu YJ; Lin SH; Din ZH; Su JH; Liu CI
    Mar Drugs; 2019 Nov; 17(12):. PubMed ID: 31783709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway.
    Ahn JH; Lee KT; Choi YS; Choi JH
    Prostaglandins Other Lipid Mediat; 2018 Jan; 134():47-56. PubMed ID: 29292033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.